Literature DB >> 21909654

Efficacy and safety of antidepressant drugs in patients with dementia.

Howard S Kirshner1.   

Abstract

Entities:  

Year:  2011        PMID: 21909654     DOI: 10.1007/s11910-011-0222-y

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


× No keyword cloud information.
  23 in total

1.  Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.

Authors:  Lon S Schneider; Pierre N Tariot; Karen S Dagerman; Sonia M Davis; John K Hsiao; M Saleem Ismail; Barry D Lebowitz; Constantine G Lyketsos; J Michael Ryan; T Scott Stroup; David L Sultzer; Daniel Weintraub; Jeffrey A Lieberman
Journal:  N Engl J Med       Date:  2006-10-12       Impact factor: 91.245

2.  Antipsychotic therapy and short-term serious events in older adults with dementia.

Authors:  Paula A Rochon; Sharon-Lise Normand; Tara Gomes; Sudeep S Gill; Geoffrey M Anderson; Magda Melo; Kathy Sykora; Lorraine Lipscombe; Chaim M Bell; Jerry H Gurwitz
Journal:  Arch Intern Med       Date:  2008-05-26

3.  Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes.

Authors:  Daniel Weintraub; Paul B Rosenberg; Lea T Drye; Barbara K Martin; Constantine Frangakis; Jacobo E Mintzer; Anton P Porsteinsson; Lon S Schneider; Peter V Rabins; Cynthia A Munro; Curtis L Meinert; Constantine G Lyketsos
Journal:  Am J Geriatr Psychiatry       Date:  2010-04       Impact factor: 4.105

4.  Cerebrovascular events among elderly nursing home patients treated with conventional or atypical antipsychotics.

Authors:  Rosa Liperoti; Giovanni Gambassi; Kate L Lapane; Claire Chiang; Claudio Pedone; Vincent Mor; Roberto Bernabei
Journal:  J Clin Psychiatry       Date:  2005-09       Impact factor: 4.384

5.  Efficacy and tolerability of carbamazepine for agitation and aggression in dementia.

Authors:  P N Tariot; R Erb; C A Podgorski; C Cox; S Patel; L Jakimovich; C Irvine
Journal:  Am J Psychiatry       Date:  1998-01       Impact factor: 18.112

6.  Risk of death in elderly users of conventional vs. atypical antipsychotic medications.

Authors:  Philip S Wang; Sebastian Schneeweiss; Jerry Avorn; Michael A Fischer; Helen Mogun; Daniel H Solomon; M Alan Brookhart
Journal:  N Engl J Med       Date:  2005-12-01       Impact factor: 91.245

7.  Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials.

Authors:  Lon S Schneider; Karen S Dagerman; Philip Insel
Journal:  JAMA       Date:  2005-10-19       Impact factor: 56.272

8.  Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS.

Authors:  Constantine G Lyketsos; Lourdes DelCampo; Martin Steinberg; Quincy Miles; Cynthia D Steele; Cynthia Munro; Alva S Baker; Jeannie-Marie E Sheppard; Constantine Frangakis; Jason Brandt; Peter V Rabins
Journal:  Arch Gen Psychiatry       Date:  2003-07

9.  The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease.

Authors:  C Holmes; D Wilkinson; C Dean; S Vethanayagam; S Olivieri; A Langley; N D Pandita-Gunawardena; F Hogg; C Clare; J Damms
Journal:  Neurology       Date:  2004-07-27       Impact factor: 9.910

10.  Behavioral effects of trazodone in Alzheimer's disease.

Authors:  F Lebert; F Pasquier; H Petit
Journal:  J Clin Psychiatry       Date:  1994-12       Impact factor: 4.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.